Overview
Childhood-onset nemaline myopathy (also called childhood-onset NM or typical nemaline myopathy) is a rare inherited neuromuscular disorder characterized by progressive or nonprogressive muscle weakness that becomes apparent during childhood, typically between 1 and 10 years of age. It belongs to the broader group of nemaline myopathies, which are defined by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) visible on muscle biopsy. The disease primarily affects skeletal muscles, leading to generalized muscle weakness that is often more prominent in proximal muscles (those closer to the trunk), facial muscles, and the muscles of the neck and limbs. Affected children may present with delayed motor milestones, difficulty running or climbing stairs, facial weakness with an elongated face, a high-arched palate, nasal speech, and reduced muscle bulk. Respiratory muscles can also be involved, potentially leading to respiratory insufficiency that may require ventilatory support. The childhood-onset form is generally considered to have a more favorable prognosis compared to the severe congenital form of nemaline myopathy, though the clinical course is variable. Some patients remain relatively stable, while others experience slow progression of weakness over time. Skeletal complications such as scoliosis, foot deformities, and joint contractures may develop. Cardiac involvement is uncommon but has been reported in rare cases. Nemaline myopathy can be caused by pathogenic variants in several genes encoding components of the thin filament of the sarcomere, including NEB (nebulin), ACTA1 (skeletal muscle alpha-actin), TPM3, TPM2, TNNT1, CFL2, KBTBD13, KLHL40, KLHL41, and LMOD3, among others. There is currently no cure or disease-specific treatment for childhood-onset nemaline myopathy. Management is supportive and multidisciplinary, including physical therapy to maintain mobility and prevent contractures, respiratory monitoring and support when needed, orthopedic interventions for skeletal deformities, and speech therapy for feeding or swallowing difficulties.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Childhood-onset nemaline myopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Childhood-onset nemaline myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Childhood-onset nemaline myopathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Childhood-onset nemaline myopathy.
Community
No community posts yet. Be the first to share your experience with Childhood-onset nemaline myopathy.
Start the conversation →Latest news about Childhood-onset nemaline myopathy
No recent news articles for Childhood-onset nemaline myopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Childhood-onset nemaline myopathy
What is Childhood-onset nemaline myopathy?
Childhood-onset nemaline myopathy (also called childhood-onset NM or typical nemaline myopathy) is a rare inherited neuromuscular disorder characterized by progressive or nonprogressive muscle weakness that becomes apparent during childhood, typically between 1 and 10 years of age. It belongs to the broader group of nemaline myopathies, which are defined by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) visible on muscle biopsy. The disease primarily affects skeletal muscles, leading to generalized muscle weakness that is often more prominent in proximal muscle
At what age does Childhood-onset nemaline myopathy typically begin?
Typical onset of Childhood-onset nemaline myopathy is childhood. Age of onset can vary across affected individuals.